The purification of hypertensin I
- PMID: 13201713
- PMCID: PMC2136385
- DOI: 10.1084/jem.100.4.363
The purification of hypertensin I
Abstract
The purification of hypertensin I has been described. The final product which is four times as powerful a pressor agent as l-arterenol, is obtained with an over-all recovery of 40 per cent. The product consists of a single component in countercurrent distribution, having a nitrogen content of 15.97 per cent and a specific activity of 7050 Goldblatt units per mg. of N or 1125 units per mg. of solid. Acid hydrolysis and paper chromatography indicate in a preliminary fashion that there are about nine amino acids present in the intact polypeptide.
Similar articles
-
The amino acid composition of hypertensin II and its biochemical relationship to hypertensin I.J Exp Med. 1956 Aug 1;104(2):183-91. doi: 10.1084/jem.104.2.183. J Exp Med. 1956. PMID: 13345963 Free PMC article.
-
The purification of hypertensin II.J Exp Med. 1956 Mar 1;103(3):301-7. doi: 10.1084/jem.103.3.301. J Exp Med. 1956. PMID: 13295488 Free PMC article.
-
Amino acid composition and electrophoretic properties of hypertensin I.J Exp Med. 1955 Oct 1;102(4):435-40. doi: 10.1084/jem.102.4.435. J Exp Med. 1955. PMID: 13263485 Free PMC article.
-
The preparation and function of the hypertensin-converting enzyme.J Exp Med. 1956 Mar 1;103(3):295-9. doi: 10.1084/jem.103.3.295. J Exp Med. 1956. PMID: 13295487 Free PMC article.
-
[REGULATION OF ALDOSTERONE SECRETION. ROLE OF THE KIDNEY AND THE RENIN-ANGIOTENSIN SYSTEM (HYPERTENSIN)].Annee Endocrinol. 1963;15:21-6. Annee Endocrinol. 1963. PMID: 14333522 Review. French. No abstract available.
Cited by
-
[Renin and hypertension, physiological or pathological agents?].Klin Wochenschr. 1958 Aug 1;36(15):693-706. doi: 10.1007/BF01493136. Klin Wochenschr. 1958. PMID: 13576750 German. No abstract available.
-
Historical perspective of the renin-angiotensin system.Mol Biotechnol. 2003 May;24(1):27-39. doi: 10.1385/MB:24:1:27. Mol Biotechnol. 2003. PMID: 12721494 Review.
-
Nutritional Supplements for the Treatment of Neuropathic Pain.Biomedicines. 2021 Jun 13;9(6):674. doi: 10.3390/biomedicines9060674. Biomedicines. 2021. PMID: 34199290 Free PMC article. Review.
-
Fibroblast growth factor stimulates angiotensin converting enzyme expression in vascular smooth muscle cells. Possible mediator of the response to vascular injury.J Clin Invest. 1995 Jan;95(1):377-87. doi: 10.1172/JCI117666. J Clin Invest. 1995. PMID: 7814638 Free PMC article.
-
[The renin-angiotensin system: methodology and clinical importance].Can Med Assoc J. 1970 Oct 17;103(8):837-43. Can Med Assoc J. 1970. PMID: 4319998 Free PMC article. Review. No abstract available.